Mechanisms of Resistance to Antibody–Drug Conjugates

SIMPLE SUMMARY: Antibody–drug conjugates (ADCs) are a growing class of therapies that aim to delivery therapy more efficiently, with fewer side effects, than conventional chemotherapy. ADCs are composed of an antibody linked to a chemotherapy payload, allowing targeted delivery of the chemotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Abelman, Rachel Occhiogrosso, Wu, Bogang, Spring, Laura M., Ellisen, Leif W., Bardia, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954407/
https://www.ncbi.nlm.nih.gov/pubmed/36831621
http://dx.doi.org/10.3390/cancers15041278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954407/
https://www.ncbi.nlm.nih.gov/pubmed/36831621
http://dx.doi.org/10.3390/cancers15041278

Ejemplares similares